- Home
- MDGL vs SNV Comparison
MDGL vs SNV Comparison
Compare MDGL & SNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- SNV
- Stock Information
- Founded
- MDGL 2011
- SNV 1888
- Country
- MDGL United States
- SNV United States
- Employees
- MDGL N/A
- SNV N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- SNV Major Banks
- Sector
- MDGL Health Care
- SNV Finance
- Exchange
- MDGL Nasdaq
- SNV Nasdaq
- Market Cap
- MDGL 6.1B
- SNV 7.2B
- IPO Year
- MDGL N/A
- SNV N/A
- Fundamental
- Price
- MDGL $424.95
- SNV $50.53
- Analyst Decision
- MDGL Strong Buy
- SNV Buy
- Analyst Count
- MDGL 10
- SNV 22
- Target Price
- MDGL $474.67
- SNV $59.05
- AVG Volume (30 Days)
- MDGL 383.6K
- SNV 1.7M
- Earning Date
- MDGL 10-30-2025
- SNV 10-15-2025
- Dividend Yield
- MDGL N/A
- SNV 3.02%
- EPS Growth
- MDGL N/A
- SNV 218.56
- EPS
- MDGL N/A
- SNV 5.20
- Revenue
- MDGL $515,547,000.00
- SNV $2,239,379,000.00
- Revenue This Year
- MDGL $394.12
- SNV $30.04
- Revenue Next Year
- MDGL $57.74
- SNV $5.40
- P/E Ratio
- MDGL N/A
- SNV $9.95
- Revenue Growth
- MDGL 3421.98
- SNV 32.95
- 52 Week Low
- MDGL $200.63
- SNV $35.94
- 52 Week High
- MDGL $457.16
- SNV $61.06
- Technical
- Relative Strength Index (RSI)
- MDGL 58.68
- SNV 47.81
- Support Level
- MDGL $425.00
- SNV $51.04
- Resistance Level
- MDGL $440.90
- SNV $52.14
- Average True Range (ATR)
- MDGL 14.17
- SNV 1.15
- MACD
- MDGL -4.03
- SNV 0.02
- Stochastic Oscillator
- MDGL 28.61
- SNV 18.14
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About SNV Synovus Financial Corp.
Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.